Annex H - Indicative non-binding estimated quantities of products requested |
Fri, 02/24/2023 - 05:53 |
Annex H - Indicative non-binding estimated quantities of products requested |
Mon, 04/11/2022 - 08:54 |
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:12 |
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/4 |
Mon, 08/28/2023 - 06:23 |
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:56 |
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:10 |
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines |
Fri, 02/24/2023 - 05:52 |
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines |
Mon, 04/11/2022 - 08:54 |
Annex F. CDP technical tender submission - instructions for use ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:56 |
Annex F - IDA code of conduct |
Fri, 02/24/2023 - 05:52 |
Annex F - IDA code of conduct |
Mon, 04/11/2022 - 08:54 |
Annex F - CDP Technical Tender Submission - Instructions for use ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:09 |
Annex E. i+solutions Code of Conduct for suppliers ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:55 |
Annex E - Purchase general terms and conditions |
Fri, 02/24/2023 - 05:51 |
Annex E - Purchase general terms and conditions |
Mon, 04/11/2022 - 08:53 |
Annex E - i+solutions Code of Conduct for Suppliers ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:08 |
Annex D: IDA model long-term agreement (LTA) |
Fri, 02/24/2023 - 05:50 |
Annex D. i+solutions model Long-Term Agreement (LTA) ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:53 |
Annex D - IDA model long-term agreement |
Fri, 02/24/2023 - 05:49 |
Annex D - IDA model long-term agreement |
Mon, 04/11/2022 - 08:53 |
Annex D - i+solutions model long-term agreement (LTA) ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:07 |
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:08 |
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/4 |
Mon, 08/28/2023 - 06:00 |
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:52 |
Annex C- List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:06 |
Annex C- List of priority countries for TB medicines registration |
Fri, 02/24/2023 - 05:49 |
Annex C- List of priority countries for TB medicines registration |
Mon, 04/11/2022 - 08:52 |
Annex B. List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:51 |
Annex B - List and technical specifications of requested products |
Fri, 02/24/2023 - 05:47 |
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:05 |
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/4 |
Mon, 08/28/2023 - 05:59 |
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:05 |
Annex B - List and technical specifications of products requested |
Mon, 04/11/2022 - 08:52 |
Annex A2 - Financial Bid Response Form |
Mon, 04/11/2022 - 08:51 |
Annex A1 - Technical Bid Response Form for Cat I&III Kit A |
Mon, 04/11/2022 - 08:51 |
Annex A. Financial Bid Response Form ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:02 |